As you know bailie, with all treatment choices, YMMV. And so it goes with Vidaza / Dacogen. For my age and local methodology of choices, the positive result percentages for CR & OS simply don't make sense - for me the risks are not worth it!
__________________
Ric: Low-risk MDS (blasts <4%); 4 cycles Revlimid no positive response; PRBC transfusion dependent; so far, 392'units' over 8 3/4 years; BMB #4 (15/04/01) shows evolution to AML (blasts 20-30%
)
47,XY,del(5) (q22q35),+21[24][cp24]/46,XY(1).